AbbVie’s elagolix meet phase III trial target
Among the pharma stocks, AbbVie (ABBV) is a company that has got an impressive reputation for growing demand...
Breaking market news, earnings coverage, and in-depth interviews with industry leaders.
Among the pharma stocks, AbbVie (ABBV) is a company that has got an impressive reputation for growing demand...
Though a diplomatic intervention by the Congress had earlier alleviated the threat of a full-fledged trade war, the...
It’s been only three months into the year, and we have already seen two popular and much-loved companies...
With more and more celeb critics raining on Snapchat’s parade, Rihanna certainly would not be handing over her...
“What you put on Facebook, stays on Facebook. (And anyone can take it).” This has been implied umpteen times...
Once the darling of the Oil & Gas industry, ExxonMobil (XOM), has now lost its sheen. Gone are...
US stocks are expected to have some heavy trading and remain on the lookout this week as the...
eBay (EBAY) is one company that often gets underplayed in retail industry discussions. While it stays safe from...
US futures are pointing to a lower open today after ending higher on Friday. Investors remained concerned on...
A few decades ago, when it was still a concept, autonomous transportation technology looked like a whacky idea...
Continuing its recovery from an acute phase of fiscal performance, jeweler Tiffany & Co. (TIF) reported strong revenues...
E-commerce giant Alibaba Group (BABA) — parent of Alibaba.com, China’s answer to Amazon and e-Bay — may soon...